Pradnya D. Patil

Pradnya D. Patil

Hematology | Oncology

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Nucleobase Ionic Liquids (NBILs) Induced Apoptosis via Caspase 3 Activation and in silico Regulation of the IRE1a Pathway in Pancreatic Cancer PANC-1 Cells.

Nucleobase Ionic Liquids (NBILs) Induced Apoptosis via Caspase 3 Activation and in silico Regulation of the IRE1a Pathway in Pancreatic Cancer PANC-1 Cells.

Journal: Anti-cancer agents in medicinal chemistry

Published: June 17, 2025

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Journal: Clinical lung cancer

Published: June 11, 2025

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Journal: Nature

Published: February 27, 2025

Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC.

Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC.

Journal: NPJ precision oncology

Published: August 01, 2024

Cold maceration extraction of wild fruit Terminalia bellirica (Gaertn.) Roxb.: exploring its bioactives for biomedical applications.

Cold maceration extraction of wild fruit Terminalia bellirica (Gaertn.) Roxb.: exploring its bioactives for biomedical applications.

Journal: Preparative biochemistry & biotechnology

Published: February 13, 2024

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Journal: Nature

Published: October 27, 2023

Can Radiomics Bridge the Gap Between Immunotherapy and Precision Medicine in Lung Cancer?

Can Radiomics Bridge the Gap Between Immunotherapy and Precision Medicine in Lung Cancer?

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 09, 2023

Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.

Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.

Journal: Clinical lung cancer

Published: February 01, 2023

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Journal: Cancer discovery

Published: December 20, 2022

A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors.

A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors.

Journal: Science advances

Published: November 25, 2022

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 07, 2022

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.

Journal: Scientific reports

Published: January 19, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026